Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-05T14:22:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, color-coded highlights for additions and deletions, and a revision banner showing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-29T06:27:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 in the page footer, with no changes to study data or record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:08:02.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-17T18:51:20.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision history now shows an addition of Revision: v3.3.2 and removal of Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-26T08:27:53.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page removed a government funding notice, which is a minor administrative change and does not affect the study record or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T08:43:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.